Dupuytren's contracture; increased cellularity - Proliferation, is there equality?

Scandinavian Journal of Surgery

Volumn 94, Issue 1, 2005, Pages 71-75

  Forsman, Minna ^a   Kallioinen, L ^b   Kallioinen, M ^a   Ryhanen J ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Dupuytren's disease; Immunohistochemistry; Recurrence

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; KI 67 ANTIGEN; MUSCLE ANTIGEN; TENASCIN;

ADULT; AGED; APONEUROSIS; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DUPUYTREN CONTRACTURE; FASCIA; FEMALE; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; MALE; MYOFIBROBLAST; RECURRENT DISEASE;

EID: 17244376175     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690509400117     Document Type: Article

References (32)

1. Tomasek JJ, Vaughan MB, Haaksma CJ: Cellular structure and biology of Dupuytren's disease. Hand Clinics 1999;15(1):21-33
2. Rudolph R, Vande Berg J: The Myofibroblast in Dupuytren's contracture. Hand Clinics 1991;7(4):683-692
3. Farsetti P, Tudisco C, Caterini R, Bellocci M: Ledderhose's disease: case study with histologic and ultrastructural analysis. Ital J Orthop Traumatol 1992;18(1):129-133
4. Sanders JL, Dodd C, Ghahary A, Scott PG, Tredget EE: The effect of interferon-alpha2b on an vitro model Dupuytren's contracture. J Hand Surg (AM) 1999;24(3):578-585
5. Ketchum LD, Donahue TK: The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg (AM) 2000;25(6):1157-1162
6. D Meek RM, McLellan S, Reilly J, Crossan JF: The effect of steroids on Dupuytren's disease: role of programmed cell death. J Hand Surg (Br) 2002;27(3):270-273
7. Kuhn MA, Wang X, Payne WG, Ko F, Robson MC: Tamoxifen decreases fibroblast function and downregulates TGF (beta2) in Dupuytren's affected palmar fascia. J Surg Res 2002;103(2): 146-152
8. Douglas C, Ross MD, FRCSC: Epidemiology of Dupuytren's disease. Hand Clinics 1999;15(1):53-62
9. Ragoowansi RH, Britto JA.: Genetic and epigenetic influences on the pathogenesis of Dupuytren's disease. J Hand Surg (AM) 2001;26(6):1157-1158
10. Finsen V, Dalen H, Nesheim J: The prevalence of Dupuytren's disease among 2 different ethnic groups in northern Norway. J Hand Surg (AM) 2002;27(1):115-117
11. Benson LS, Williams CS, Kahle M: Dupuytren's contracture. J Am Acad Orthop Surg 1998;6(1):24-35
12. Magro G, Lanteri E, Micali G, Paravizzini G, Travail S, Lanzafame S: Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor. J Pathol 1997;181(2):213-217
13. Rayan GM, Tomasek JJ: Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts. Tissue Cell 1994;26(5):747-756
14. Quaglino D, Bergamini G, Croce A, Boraldi F, Barbieri D, Caroli A, Marcuzzi A, Tiozzo R, Ronchetti IP: Cell behavior and cell-matrix interactions of human palmar aponeurotic cells in vitro. J Cell Physiol 1997;173(3):415-422
15. Wilutzky B, Berndt A, Katenkamp D, Koshmehl H: Programmed cell death in nodular palmar fibromatosis (Morbus Dupuytren). Histol Histopathol 1998;13(1):67-72
16. Melling M, Karimian-Teherani D, Mostler S, Behnam M, Sobal G, Menzel EJ: Changes of biochemical properties in Dupuytren disease. Arch Pathol lab Med 2000;124(9):1275-1281
17. Bricley-Parsons D, Glimcher MJ, Smith RJ, Albin R, Adams JP: Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg(AM) 1981;63(5):787-797
18. Menzel EJ, Piza H, Zielinski C, Endler AT, Steffen C, Millesi H: Collagen types and anticollagen-antibodies in Dupuytren's disease. Hand 1979;11(3):243-248
19. Pereira RS, Black CM, Turner SM, Spencer JD: Antibodies to collagen types I-VI in Dupuytren's contracture. J Hand Surg(Br) 1986;11(1):58-60
20. Fitzgerald AM, Kirkpatrick JJ, Naylor IL: Dupuytren's disease. The way forward? J Hand Surg (Br) 1999;24(4):395-399
21. Meek RMD, McLellan S, Crossan JF: Dupuytren's disease: A Model for the mechanism of fibrosis and its modulation by steroids. J Bone Joint Surg 1999;81-B(4):732-738
22. Andrew JG, Andrew SM, Ash A, Turner B: An investigation into the role of inflammatory cells in Dupuytren's disease. J Hand Surg (Br) 1991;16(3):267-271
23. Alioto RJ, Rosier RN, Burton RI, Puzas JE: Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia. J Hand Surg (AM) 1994;19(3):442-452
24. Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K: The role of transforming growth factor beta in Dupuytren's disease. J Hand Surg (AM) 1996;21(2):210-215
25. Moulin V, Castilloux G, Auger FA, Garrel D, O'Connor-McCourt MD, Germain L: Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts. Exp Cell Res 1998 10;238(1):283-293
26. Bunker TD, Reilly J, Baird KS, Hamblen DL: Expression of growth factors, cytokines and matrix metalloproteinases in frozen shoulder. J Bone Joint Surg (Br) 2000;82(5):768-773
27. Tarlton JF, Meagher P, Brrown RA, McGrouther DA, Bailey AJ, Afoke A: Mechanical stress in vitro induces increased expression of MMPs 2 and 9 in excised Dupuytren's disease tissue. J Hand Surg (Br) 1998;23(3):291-296
28. Hutchinson JW, Tierney GM, Parsons SL, Davis TRC: Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor. J Bone Joint Surg Br 1998;80-B(5):907-908
29. Hueston JT, Murrell GA: Cell-controlling factors in Dupuytren's contracture. Ann Hand Surg 1990;9(2):135-137
30. George AC, Murrell MBBS, Dphil: The Role of the Fibroblast in Dupuytren's Contracture. Hand Clinics 1991 Nov;7(4):669-680
31. Pagnotta A, Specchia N, Greco F: Androgen receptors in Dupuytren's contracture. J Orthop Res 2002;20(1):163-168
32. Willbrand S: Dupuytren's contracture: Features and consequences, Doctoral thesis, 2002 Uppsala